Host and gut microbiota symbiotic factors: lessons from inflammatory bowel disease and successful symbionts

@article{Ballal2011HostAG,
  title={Host and gut microbiota symbiotic factors: lessons from inflammatory bowel disease and successful symbionts},
  author={Sonia Arora Ballal and Carey Ann Gallini and N. Segata and Curtis Huttenhower and Wendy S. Garrett},
  journal={Cellular Microbiology},
  year={2011},
  volume={13},
  url={https://api.semanticscholar.org/CorpusID:205529660}
}
Considering features of human resident gut bacteria provides the opportunity to understand how microbes have achieved their symbiont status, and high‐throughput approaches are becoming increasingly practical for functionally characterizing the gut microbiota as a community.

Functional profiling of the gut microbiome in disease-associated inflammation

Functional profiling of the human microbiome using metagenomic and metatranscriptomic approaches is discussed, focusing on the implications for inflammatory conditions such as inflammatory bowel disease and rheumatoid arthritis.

Compositional changes in human gut microbiota reveal a putative role of intestinal mycobiota in metabolic and biological decline during aging

Differences in gut microbiota composition of the older individuals showed increase in genera Bacteroides, Blautia, Ruminococcaceae, and Escherichia coli and significant reduction in fungi belonging to saccharomyces cerevisiae and candida albicans in comparison to their younger counterparts.

Assessing the Intestinal Microbiota in the SHINE Trial

The evidence for a link between the developing infant gut microbiota, infant feeding, EED, and stunting is reviewed, and the potential causal pathways relating these variables are discussed, by capitalizing on the longitudinal design and randomized interventions of the Sanitation Hygiene Infant Nutrition Efficacy trial in Zimbabwe.

Symbiosis as the way of eukaryotic life: The dependent co-origination

Symbionts have also been found to constitute a second mode of genetic inheritance, providing selectable genetic variation for natural selection and develop as multi-genomic consortia/teams/ecosystems.

Interactions in the microbiome: communities of organisms and communities of genes

This work identifies some promising avenues of research that are likely to yield a deeper understanding of microbial communities that shift from observation-based questions of ‘Who is there?' and 'What are they doing?' to the mechanistically driven question of 'How will they respond?'

Symbiosis as the way of eukaryotic life: The dependent co-origination of the body

Symbionts have also been found to constitute a second mode of genetic inheritance, providing selectable genetic variation for natural selection and develop as multi-genomic consortia/teams/ecosystems.

Bacterial communities in digestive and excretory organs of cicadas

Bacteriocyte-associated symbionts are essential for the health of many sap-sucking insects, such as cicadas, leafhoppers and treehoppers, etc., but little is known about the bacterial community in

Kutty M.V.H

Manipulation of gut microbiota can be used to alleviate disease conditions like obesity, inflammatory bowel disease, autism through establishment of healthy microbiota.

Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm

It is argued that a mechanistic understanding of the microbial symbiosis in the vertebrate gut and its evolution will be important to determine how this relationship can go awry, and it may reveal possibilities by which the gut microbiome can be manipulated to support health.

A microbial symbiosis factor prevents intestinal inflammatory disease

It is reported here that the prominent human symbiont Bacteroides fragilis protects animals from experimental colitis induced by Helicobacter hepaticus and that molecules of the bacterial microbiota can mediate the critical balance between health and disease.

Helicobacter bilis: bacterial provocateur orchestrates host immune responses to commensal flora in a model of inflammatory bowel disease

Most published mouse studies evaluating the pathogenesis of inflammatory bowel disease (IBD) therefore simply refer to gut flora as altered Schaedler flora (ASF), and monitoring of the gnotobiotic animals relied on examining the morphology of the microorganisms with a limited evaluation of the organisms, biochemical traits and growth characteristics.

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

It is demonstrated that PSA is not only able to prevent, but also cure experimental colitis in animals, and co-opts the Treg lineage differentiation pathway in the gut to actively induce mucosal tolerance.

Beneficial effects of Bacteroides fragilis polysaccharides on the immune system.

Polysaccharide A can provide protection in animal models of colitis through repression of pro-inflammatory cytokines associated with the Th17 lineage and the resulting immunomodulatory effects.
...